Vimarsana
Biggest News Aggregation in the World

Amy Conrad News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amy Conrad. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amy Conrad Today - Breaking & Trending Today

Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation - Vimarsana News

Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation

/PRNewswire/ -- Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address...

Sapience Therapeutics to Showcase Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 - Vimarsana News

Sapience Therapeutics to Showcase Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024

/PRNewswire/ -- Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address...

GV20 Therapeutics to Present at the Jefferies Healthcare Conference Private Biotech Day - Vimarsana News

GV20 Therapeutics to Present at the Jefferies Healthcare Conference Private Biotech Day

/PRNewswire/ -- GV20 Therapeutics, a clinical-stage biotechnology company integrating AI, genomics, and disease biology to create next-generation antibody...

Renibus Therapeutics Announces Oral Presentations on RBT-1 at AATS and SCA Medical Conferences - Vimarsana News

Renibus Therapeutics Announces Oral Presentations on RBT-1 at AATS and SCA Medical Conferences

/PRNewswire/ -- Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and...

Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer - Vimarsana News

Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer

/PRNewswire/ -- Congruence Therapeutics, a leading computationally-driven biotechnology company developing a pipeline of novel small molecules for diseases...